Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2010
03/18/2010US20100068262 Method and Compositions for Stimulation of an Immune Response to PSMA using a Xenogeneic PSMA Antigen
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068244 Stabilized biodegradable neurotoxin implants
03/18/2010US20100068227 Composition Useful as a Vaccine
03/18/2010US20100068226 Polynucleotides and Uses Thereof
03/18/2010US20100068220 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby
03/18/2010US20100068219 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide
03/18/2010US20100068212 Targeting pathogenic monocytes
03/18/2010US20100068203 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies
03/18/2010US20100068193 Methods and materials for the generation of regulatory t cells
03/18/2010US20100068180 Novel methods for modulating inflammatory and/or immune responses
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068175 Methods of using Fc-Cytokine fusion proteins
03/18/2010US20100068136 Anti-CD19 Antibodies
03/18/2010CA2737056A1 Targeting pathogenic monocytes
03/18/2010CA2736829A1 Pd-1 specific antibodies and uses thereof
03/18/2010CA2736816A1 Pd-1 specific antibodies and uses thereof
03/18/2010CA2735368A1 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/18/2010CA2699220A1 Use of a peptide as a therapeutic agent
03/17/2010EP2163896A1 Method for detection or treatment of graft versus host disease
03/17/2010EP2163626A1 Human FGF-21 gene and gene expression products
03/17/2010EP2163614A1 Porcine animals lacking any expression of functional alpha 1, 3, galactosyltransferase
03/17/2010EP2163562A2 IL-1beta binding antibodies and fragments thereof
03/17/2010EP2163557A1 Function-selective vitamin d receptor agonist
03/17/2010EP2163554A1 Pyrimidodiazepinone derivative
03/17/2010EP2163253A1 Extracts from the plant hornstedtia scyphifera and immnunosuppressive effects thereof
03/17/2010EP2162150A1 Vaccine against clostridium perfringens
03/17/2010EP1817300B1 Potentiators of glutamate receptors
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1506225B2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
03/17/2010EP1335689B1 Loratadine transdermal administration system and use thereof
03/17/2010CN101675079A Binding members for ige molecules
03/17/2010CN101675048A 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
03/17/2010CN101674841A Anti-histamine substance and method for production thereof
03/17/2010CN101671638A New strain of bifidobacterium and fermentative preparation method and application thereof
03/17/2010CN101671637A Method for culturing solid nutrient carrier of intestinal probiotics
03/17/2010CN101671620A Green turtle tea liquor and preparation method thereof
03/17/2010CN101671618A Penes wine and preparation method thereof
03/17/2010CN101670119A polynucleotide
03/17/2010CN101670086A Chinese medicinal health wine
03/17/2010CN101670054A Chinese medicinal material with multiple efficacies
03/17/2010CN101670039A Traditional Chinese medicine for curing lupus erythematosis and preparation method thereof
03/17/2010CN101669984A Anti-fatigue immuno-regulation Chinese medicinal product
03/17/2010CN101669982A Radix isatidis dispersible tablet and preparation technology thereof
03/17/2010CN101669973A Biological immunopotentiator composition for treating cancers
03/17/2010CN101669969A Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
03/17/2010CN101669962A Composite glycyrrhizic acid amino acid injection, and preparation method as well as applications thereof
03/17/2010CN101669961A Method for producing Chinese-western compound preparation for preventing and treating animal synthetic respiratory diseases
03/17/2010CN101669926A Liquid preparation for dosing nasal cavities and method for making the same
03/17/2010CN101669913A Levocetirizine dihydrochloride granule and preparation and detection methods thereof
03/17/2010CN101669905A Thymosin alpha1 injection-type subcutaneous implant
03/17/2010CN101669899A Sustained-release implant taking maize protein as main framework material or matrix and use thereof
03/16/2010US7678918 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents
03/16/2010US7678915 Process for production of piperidine derivatives
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678822 inhibiting rejection of a transplanted organ, tissue or cell in a recipient mammal; immunosuppressive agent; autoimmune diseases
03/16/2010US7678777 increase a person immunity by oral administering a mixture including a dextran, promoting the cell growth and colonizing in the intestine of a subject without supplying L. casei subsp. casei at all times
03/16/2010US7678758 For enhancing T cell response to tumour cells
03/16/2010US7678558 Method for overexpression of zwitterionic polysaccharides
03/16/2010US7678552 Method for selecting therapeutic agents for cancer treatment
03/16/2010US7678376 Recombinant parainfluenza virus expression systems and vaccines
03/16/2010CA2510519C Condensed furan compounds
03/16/2010CA2459981C For producing biologically active products
03/16/2010CA2438646C Pyrimidine derivatives for inhibition of cell-proliferation
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2436724C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2395121C Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
03/16/2010CA2372575C Bradykinin receptor antagonists
03/16/2010CA2336846C Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric g protein
03/16/2010CA2327311C Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
03/11/2010WO2010028116A1 Macrocyclics pyrimidines as aurora kinase inhibitors
03/11/2010WO2010028015A2 2-oxo-1,2-dihydro-quinoline modulators of immune function
03/11/2010WO2010027762A1 Indolizine inhibitors of leukotriene production
03/11/2010WO2010027567A2 Tricyclic spirocycle derivatives and methods of use thereof
03/11/2010WO2010027431A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
03/11/2010WO2010027189A2 A new use for homoisoflavanone or a salt thereof
03/11/2010WO2010027094A1 NKT CELL-DERIVED iPS CELLS AND NKT CELLS DERIVED THEREFROM
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026873A1 Novel compound ceramidastin, process for production thereof, and use thereof
03/11/2010WO2010026660A1 Rna capable of inhibiting expression of zfat gene
03/11/2010WO2010026489A1 Innate immunity modulators
03/11/2010WO2010026128A1 N-(3-methyl-5-isoquinolinyl)-n'-((3r)-1-[5-(trifluoromethyl)-2-pyridinyl]-3-pyrrolidinyl) urea for the treatment of rhinitis
03/11/2010WO2010025630A1 Sodium cholate-included prednisone intercalated layered double hydroxides and preparation method thereof
03/11/2010WO2010025542A1 Lps based vaccines
03/11/2010WO2010025541A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen
03/11/2010WO2009158431A3 Pyrimidine derivatives as kinase inhibitors
03/11/2010WO2009155041A3 Method to modulate hematopoietic stem cell growth
03/11/2010WO2009142772A3 Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
03/11/2010WO2009134429A3 Methods and compositions for modulating immunological tolerance
03/11/2010WO2009095646A3 Peptides from factor viii
03/11/2010US20100063130 Method for promoting immune response comprising inhibiting cd22 function in b cells
03/11/2010US20100063108 Pyridin-4-yl derivatives as immunomodulating agents
03/11/2010US20100063103 (3-{[2-(Benzenesulfonyl)pyridin-3-yl]methyl}-5-fluoro-2-methylindol-1-yl)-acetic acid, used in the treatment of allergic or inflammatory diseases mediated by prostaglandin D2 (PGD2) or other agonists acting at the oattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) receptor
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063051 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 1172